• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证通过简化阴性和阳性症状访谈获得的六项目正负症状量表在门诊精神分裂症患者中的评分。

Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.

机构信息

Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

J Psychopharmacol. 2022 Nov;36(11):1208-1217. doi: 10.1177/02698811221131992. Epub 2022 Oct 21.

DOI:10.1177/02698811221131992
PMID:36268705
Abstract

BACKGROUND

The six-item Positive and Negative Syndrome Scale (PANSS-6) is a measure of the severity of core symptoms of schizophrenia, which can be administered via the brief Simplified Negative and Positive Symptoms Interview (SNAPSI). A recent study has confirmed the validity of PANSS-6 ratings as derived by SNAPSI (PANSS-6) among inpatients with schizophrenia.

AIMS

We aimed to test the validity of PANSS-6 among outpatients with schizophrenia using PANSS-6 ratings extracted from the 30-item PANSS-30 as derived by the Structured Clinical Interview for the Positive and Negative Syndrome Scale (PANSS-6) as a gold standard reference.

METHODS

PANSS-6 and PANSS-6 ratings were obtained at two time points by independent raters with established inter-rater reliability. Agreement between PANSS-6 and PANSS-6 ratings was estimated via intra-class coefficients (ICCs) and responsiveness over time was quantified using Spearman's rank correlation coefficients. Post hoc "leave-one-out" analyses were carried out, in which each rater in turn was excluded from the ICC calculations.

RESULTS

Seventy-three outpatients with schizophrenia participated in the study (mean age: 38.3 years; 56% males). The ICC for PANSS-6 versus PANSS-6 was 0.67 [95%CI = 0.56-0.76] and the Spearman's rank correlation coefficient for responsiveness was 0.40 ( = 0.004). When data from a specific outlying rater were excluded, the ICC for PANSS-6 versus PANSS-6 was 0.75 [95% CI = 0.63-0.83] and the Spearman's rank correlation coefficient for responsiveness was 0.55 ( = 0.018).

CONCLUSIONS

We found PANSS-6 ratings to have acceptable clinical validity, suggesting that PANSS-6 can be used for both inpatients and outpatients with schizophrenia.

摘要

背景

六项目阳性和阴性症状量表(PANSS-6)是一种衡量精神分裂症核心症状严重程度的量表,可以通过简化的阴性和阳性症状访谈(SNAPSI)进行管理。最近的一项研究证实了通过 SNAPSI(PANSS-6)得出的 PANSS-6 评分在住院精神分裂症患者中的有效性。

目的

我们旨在通过使用结构化临床访谈阳性和阴性综合征量表(PANSS-6)作为金标准参考,从 30 项 PANSS-30 中提取 PANSS-6 评分,来测试门诊精神分裂症患者中 PANSS-6 的有效性。

方法

由两位具有既定组内信度的独立评估者在两个时间点获得 PANSS-6 和 PANSS-6 评分。通过组内相关系数(ICC)评估 PANSS-6 与 PANSS-6 评分之间的一致性,并使用 Spearman 等级相关系数来量化随时间的反应性。进行事后“逐一剔除”分析,其中每个评估者依次从 ICC 计算中剔除。

结果

73 名门诊精神分裂症患者参与了研究(平均年龄:38.3 岁;56%为男性)。PANSS-6 与 PANSS-6 之间的 ICC 为 0.67[95%CI=0.56-0.76],反应性的 Spearman 等级相关系数为 0.40(=0.004)。当剔除特定的异常评估者的数据时,PANSS-6 与 PANSS-6 之间的 ICC 为 0.75[95%CI=0.63-0.83],反应性的 Spearman 等级相关系数为 0.55(=0.018)。

结论

我们发现 PANSS-6 评分具有可接受的临床有效性,表明 PANSS-6 可用于住院和门诊精神分裂症患者。

相似文献

1
Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.验证通过简化阴性和阳性症状访谈获得的六项目正负症状量表在门诊精神分裂症患者中的评分。
J Psychopharmacol. 2022 Nov;36(11):1208-1217. doi: 10.1177/02698811221131992. Epub 2022 Oct 21.
2
Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.简化阴性和阳性症状访谈获得的六项目正负症状量表评分的临床验证。
J Psychopharmacol. 2021 Sep;35(9):1081-1090. doi: 10.1177/0269881121996890. Epub 2021 Mar 28.
3
Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).使用简化正负症状访谈(SNAPSI)获得的六项阳性和阴性症状量表(PANSS-6)评分的评分者间信度。
Nord J Psychiatry. 2018 Aug;72(6):431-436. doi: 10.1080/08039488.2018.1492014. Epub 2018 Jul 24.
4
Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).六项目阳性和阴性症状量表(PANSS-6)评定的标准化培训。
Schizophr Res. 2021 Feb;228:438-446. doi: 10.1016/j.schres.2020.12.044. Epub 2021 Feb 9.
5
Bridging the Measurement Gap Between Research and Clinical Care in Schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and Other Assessments Based on the Simplified Negative and Positive Symptoms Interview (SNAPSI).弥合精神分裂症研究与临床护理之间的测量差距:阳性和阴性症状量表-6(PANSS-6)以及基于简化阴性和阳性症状访谈(SNAPSI)的其他评估
Innov Clin Neurosci. 2017 Dec 1;14(11-12):68-72.
6
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.《卡尔加里精神分裂症抑郁量表西班牙语版的跨文化改编与验证》
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
7
Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.精神分裂症阳性和阴性症状量表结构化临床访谈的评分者间信度。
Acta Psychiatr Scand. 1994 Mar;89(3):192-5. doi: 10.1111/j.1600-0447.1994.tb08091.x.
8
Assessing positive and negative symptoms in children and adolescents.评估儿童和青少年的阳性及阴性症状。
Am J Psychiatry. 1994 Feb;151(2):249-53. doi: 10.1176/ajp.151.2.249.
9
The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.阳性与阴性症状量表及简明精神病评定量表。信度、可比性及预测效度。
J Nerv Ment Dis. 1992 Nov;180(11):723-8. doi: 10.1097/00005053-199211000-00007.
10
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.精神分裂症急性症状患者中临床医生评定的个人和社会表现量表的信度、效度及检测变化的能力。
Curr Med Res Opin. 2009 Feb;25(2):325-38. doi: 10.1185/03007990802611919.

引用本文的文献

1
Risperidone ISM: review and update of its usefulness in all phases of schizophrenia.利培酮个体稳态模型:对其在精神分裂症各阶段效用的综述与更新
Ther Adv Psychopharmacol. 2024 Oct 4;14:20451253241280046. doi: 10.1177/20451253241280046. eCollection 2024.
2
Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?是否要求提供信息者获得阳性和阴性症状量表(PANSS)的有效评分?
Schizophrenia (Heidelb). 2023 Aug 31;9(1):54. doi: 10.1038/s41537-023-00378-5.
3
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials.
阳性和阴性症状量表(PANSS)-30、其主要子量表加 PANSS-6 的初始严重程度,以及与随后的改善和试验脱落的关系:18 项安慰剂对照利培酮和帕利哌酮试验的汇总参与者水平分析。
Transl Psychiatry. 2023 Jun 7;13(1):191. doi: 10.1038/s41398-023-02491-6.